• 1. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 2. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 3. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 4. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 5. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453

Introduction to 2-Methyl-2,7-diazaspiro[4.4]nonane dihydrochloride (CAS No. 91188-26-0)

2-Methyl-2,7-diazaspiro[4.4]nonane dihydrochloride, identified by its CAS number 91188-26-0, is a compound of significant interest in the field of medicinal chemistry and pharmacology. This spirocyclic diamine derivative has garnered attention due to its unique structural features and potential biological activities, making it a valuable candidate for further research and development in drug discovery.

The molecular structure of 2-Methyl-2,7-diazaspiro[4.4]nonane dihydrochloride consists of a spirocyclic framework, which is a key feature contributing to its distinct chemical properties. The spirocyclic core is formed by the fusion of two rings, specifically a piperazine ring and a cyclohexane ring, which introduces rigidity and conformational constraints to the molecule. This structural motif is often exploited in medicinal chemistry to enhance binding affinity and selectivity towards biological targets.

The presence of two amine groups at the 2 and 7 positions of the spirocyclic structure makes 2-Methyl-2,7-diazaspiro[4.4]nonane dihydrochloride a versatile scaffold for the development of bioactive molecules. The amine functionalities can participate in various chemical reactions, including hydrogen bonding and ionic interactions, which are crucial for the design of drugs that interact with biological macromolecules such as proteins and nucleic acids.

The dihydrochloride salt form of this compound enhances its solubility in aqueous solutions, making it more suitable for formulation into pharmaceutical products and biological assays. This solubility advantage is particularly important for drug candidates that require oral or parenteral administration, as it facilitates their absorption and distribution within the body.

Recent research in the field of spirocyclic compounds has highlighted their potential as pharmacophores in the development of novel therapeutic agents. Studies have demonstrated that spirocyclic diamines can exhibit a wide range of biological activities, including antimicrobial, anti-inflammatory, and anticancer properties. The unique structural features of 2-Methyl-2,7-diazaspiro[4.4]nonane dihydrochloride make it an attractive candidate for further exploration in these areas.

In particular, the spirocyclic core of this compound has been shown to mimic the binding pockets of certain enzymes and receptors, leading to potent inhibitory effects. For instance, derivatives of spirocyclic diamines have been investigated for their ability to inhibit kinases and other enzymes involved in cancer progression. The methyl group at the 2-position further modulates the electronic properties of the molecule, potentially enhancing its interaction with biological targets.

The amine groups in 2-Methyl-2,7-diazaspiro[4.4]nonane dihydrochloride also provide opportunities for further derivatization, allowing researchers to fine-tune its biological activity. By introducing various substituents at these positions, new analogs can be synthesized and evaluated for their pharmacological properties. This flexibility makes this compound a valuable tool for medicinal chemists seeking to develop novel drugs with improved efficacy and reduced side effects.

Advances in computational chemistry have also played a significant role in the study of 2-Methyl-2,7-diazaspiro[4.4]nonane dihydrochloride. Molecular modeling techniques have been used to predict the binding modes of this compound with potential biological targets, providing insights into its mechanism of action. These computational studies have guided experimental efforts and helped optimize the structure-activity relationships (SAR) of spirocyclic diamines.

Additionally, synthetic methodologies have been developed to facilitate the preparation of complex derivatives of 2-Methyl-2,7-diazaspiro[4.4]nonane dihydrochloride. These methods often involve multi-step reactions that require careful optimization to ensure high yields and purity. The synthesis of such compounds has been made more efficient through the use of novel catalysts and reaction conditions.

The potential applications of 2-Methyl-2,7-diazaspiro[4.4]nonane dihydrochloride extend beyond traditional small-molecule drug discovery. Its unique structural features make it a promising candidate for use in biotechnology applications, such as enzyme inhibitors and ligands for targeted therapy. Furthermore, its ability to form stable complexes with other molecules suggests potential uses in materials science and nanotechnology.

In conclusion, 2-Methyl-2,7-diazaspiro[4.4]nonane dihydrochloride (CAS No. 91188-26-0) is a compound with significant potential in medicinal chemistry and pharmacology due to its unique structural features and versatile biological activities. Further research is warranted to explore its full therapeutic potential and develop novel derivatives with improved properties.

• 1164467-08-6(2,7-Diazaspiro[4.4]nonane, 2-ethyl-, (Hydrochloride) (1:1))
• 130065-61-1(Atiprimod Dihydrochloride)
• 91188-35-1(2,7-Diazaspiro[4.4]nonane, 2-ethyl-, dihydrochloride)
• 135380-53-9(2-Methyl-2,7-diazaspiro[4.4]nonane)
• 124796-27-6(2-Azaspiro[4.5]decane-2-propanamine,N,N-dimethyl-8,8-dipropyl-, hydrochloride (1:2))
• 763883-32-5(2-Ethyl-2,7-diazaspiro[4.4]nonane)
• 788766-67-6(Methyl,[4-(aminomethyl)-1-methyl-4-(1-methylethyl)-3-pyrrolidinyl]-, cis- (9CI))
• 790152-51-1(Methyl,[4-(aminomethyl)-1-methyl-3-(1-methylethyl)-3-pyrrolidinyl]- (9CI))
• 1086395-66-5(2-Methyl-2,7-diazaspiro4.5decane)
• 6311-29-1(2H-Isoindole-2-propanamine,octahydro-N,N-dimethyl-, hydrochloride (1:2))